Clinicohistoradiological and surgical outcome in diffuse midline glioma.

Arvind Kumar SumanSuchanda BhattacharjeeMegha S UppinSyed Tazeem Fathima

Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2023)

DMG with H3K27M mutation in newly classified Central Nervous System tumor are WHO grade IV Tumors, comprising H3K27M mutation as molecular marker for diagnosis and related with a poor prognosis.

Keyphrases

poor prognosis
long non coding rna
cerebrospinal fluid
single molecule